癌症特征中的SHCBP1的作用:分子机制和治疗影响
Hye-Youn Kim1, Ye-Jin Park2, Soyeon Ryu2
1Department of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon 21999, Republic of Korea.
International journal of molecular sciences
|September 27, 2025
概括
SHCBP1 (SHC SH2域结合蛋白1) 是癌症的关键调节者,驱动癌症的扩散和免疫逃避. 向SHCBP1有望限制瘤生长并改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- SHCBP1 (SHC SH2域结合蛋白1) 与癌症生物学有关.
- 它在细胞分裂,增殖,亡抵抗和免疫逃避中发挥作用.
- 在许多癌症中,SHCBP1过度表达,与预后不佳相关.
研究的目的:
- 审查SHCBP1.1的分子特性.
- 探索其调节网络和癌症进展中的作用.
- 讨论其作为预后标记物和治疗点的潜力.
主要方法:
- 对SHCBP1在癌症中的功能进行文献综述.
- 对SHCBP1与癌症攻击性和预后的关联进行分析.
- 检查关于SHCBP1抑制的临床前数据.
主要成果:
- SHCBP1 调节关键的致癌过程,包括增殖,亡抵抗,EMT 和免疫逃避.
- 升高的SHCBP1表达与侵袭性瘤和患者的不良结果有关.
- 临床前研究表明,SHCBP1的枯竭抑制了瘤的生长和转移.
结论:
- SHCBP1是瘤发病的一个重要贡献者,具有广泛的致癌功能.
- SHCBP1代表了癌症治疗的有前途的治疗标.
- 需要进一步的研究来开发选择性的SHCBP1抑制剂.
相关概念视频
Hedgehog Signaling Pathway
9.8K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.8K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K


